Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,66 USD | +7,79% | +1,25% | +5,88% |
30/04 | LEXICON PHARMACEUTICALS, INC. : Ladenburg Thalmann bevestigt koopadvies | ZM |
29/04 | Lexicon Pharmaceuticals' Chief Executive Lonnel Coats gaat met pensioen | MT |
Omzet 2024 * | 25,81 mln. 24,19 mln. | Omzet 2025 * | 77,52 mln. 72,64 mln. | Marktkapitalisatie | 379 mln. 355 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -199 mln. -186 mln. | Nettowinst (verlies) 2025 * | -193 mln. -181 mln. | EV/omzet 2024 * | 14,7 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 4,89 x |
K/w-verhouding 2024 * |
-2,17
x | K/w-verhouding 2025 * |
-2,43
x | Werknemers | 285 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,99% |
Recentste transcriptie over Lexicon Pharmaceuticals, Inc.
1 dag | -1,28% | ||
1 week | -4,35% | ||
1 maand | -35,83% | ||
3 maanden | -17,65% | ||
6 maanden | +24,19% | ||
Lopend jaar | +0,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lonnel Coats
CEO | Chief Executive Officer | 58 | 07-07-14 |
Jeffrey Wade
DFI | Director of Finance/CFO | 59 | 01-01-99 |
Craig Granowitz
CTO | Chief Tech/Sci/R&D Officer | 60 | 02-08-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Lefkowitz
BRD | Director/Board Member | 80 | 01-02-01 |
Ray Debbane
CHM | Chairman | 69 | 01-08-07 |
Director/Board Member | 65 | 28-08-07 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 9 M€ | +4,89% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
01-05-24 | 1,61 | +4,55% | 2 834 859 |
30-04-24 | 1,54 | -1,28% | 3 573 328 |
29-04-24 | 1,56 | -1,27% | 2 213 745 |
26-04-24 | 1,58 | +2,60% | 1 271 998 |
25-04-24 | 1,54 | -3,75% | 1 686 207 |
uitgestelde koers Nasdaq, 30 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,65% | 379 mln. | |
-3,46% | 102 mld. | |
+1,41% | 96,09 mld. | |
+2,13% | 22,28 mld. | |
-15,84% | 21,4 mld. | |
-10,07% | 18,14 mld. | |
-39,98% | 17,02 mld. | |
-14,65% | 16,09 mld. | |
+4,39% | 13,83 mld. | |
+31,35% | 11,97 mld. |